DE60120942D1 - Verbessertes verfahren für reverses n-hybrid-screening - Google Patents

Verbessertes verfahren für reverses n-hybrid-screening

Info

Publication number
DE60120942D1
DE60120942D1 DE60120942T DE60120942T DE60120942D1 DE 60120942 D1 DE60120942 D1 DE 60120942D1 DE 60120942 T DE60120942 T DE 60120942T DE 60120942 T DE60120942 T DE 60120942T DE 60120942 D1 DE60120942 D1 DE 60120942D1
Authority
DE
Germany
Prior art keywords
inhibitors
antagonists
interactions
hybrid screening
reverse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60120942T
Other languages
English (en)
Other versions
DE60120942T2 (de
Inventor
Richard Hopkins
Ilya Serebriiskii
Michael Watt
Erica Golemis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phylogica Ltd
Original Assignee
Phylogica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ6131A external-priority patent/AUPQ613100A0/en
Priority claimed from AUPQ6437A external-priority patent/AUPQ643700A0/en
Priority claimed from AUPQ6830A external-priority patent/AUPQ683000A0/en
Priority claimed from AUPR1256A external-priority patent/AUPR125600A0/en
Application filed by Phylogica Ltd filed Critical Phylogica Ltd
Publication of DE60120942D1 publication Critical patent/DE60120942D1/de
Application granted granted Critical
Publication of DE60120942T2 publication Critical patent/DE60120942T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Fuses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Special Wing (AREA)
DE60120942T 2000-03-08 2001-03-08 Verbessertes verfahren für reverses n-hybrid-screening Expired - Fee Related DE60120942T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
AUPQ6131A AUPQ613100A0 (en) 2000-03-08 2000-03-08 Improved reverse two hybrid screening method
AUPQ613100 2000-03-08
AUPQ6437A AUPQ643700A0 (en) 2000-03-23 2000-03-23 Improved high-throughput reverse two hybrid screening method
AUPQ643700 2000-03-23
AUPQ6830A AUPQ683000A0 (en) 2000-04-11 2000-04-11 Improved high-throughput reverse two-hybrid/reverse three- hybrid screening method
AUPQ683000 2000-04-11
AUPR1256A AUPR125600A0 (en) 2000-11-06 2000-11-06 Dual fluorescent reporter construct for two hybrid and reverse two hybrid screening applications
AUPR125600 2000-11-06
PCT/US2001/007669 WO2001066787A1 (en) 2000-03-08 2001-03-08 Improved reverse n-hybrid screening method

Publications (2)

Publication Number Publication Date
DE60120942D1 true DE60120942D1 (de) 2006-08-03
DE60120942T2 DE60120942T2 (de) 2007-02-01

Family

ID=27424505

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120942T Expired - Fee Related DE60120942T2 (de) 2000-03-08 2001-03-08 Verbessertes verfahren für reverses n-hybrid-screening

Country Status (5)

Country Link
EP (1) EP1268842B1 (de)
AT (1) ATE331038T1 (de)
CA (1) CA2402111A1 (de)
DE (1) DE60120942T2 (de)
WO (1) WO2001066787A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211063A1 (de) * 2002-03-13 2003-10-09 Axaron Bioscience Ag Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo
AU2003900786A0 (en) * 2003-02-21 2003-03-13 Phylogica Limited Methods of regulating gene expression
AU2004243340B2 (en) * 2003-05-30 2009-01-08 Phylogica Limited An improved genetic screen for interaction interface mapping
CN1827763B (zh) * 2005-10-21 2010-04-14 中国人民解放军军事医学科学院基础医学研究所 筛选蛋白质解离肽的双启动子酵母随机肽库的构建方法
GB201420218D0 (en) * 2014-11-13 2014-12-31 Cambridge Entpr Ltd A method of screening for modulation of cell signalling pathways
BR112018074472A2 (pt) 2016-05-27 2019-03-19 Synthex, Inc. interfaces proteicas
GB2584210B (en) 2017-11-22 2022-03-16 Synthex Inc Peptides for inhibiting RAD51

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
ATE352638T1 (de) * 1995-04-11 2007-02-15 Gen Hospital Corp REVERSE ßTWO-HYBRIDß-SYSTEME
US6326150B1 (en) * 1997-09-16 2001-12-04 Fox Chase Cancer Center Yeast interaction trap assay
CA2317816C (en) * 1998-01-09 2009-02-17 Tvw Telethon Institute For Child Health Research Peptide detection method

Also Published As

Publication number Publication date
CA2402111A1 (en) 2001-09-13
EP1268842B1 (de) 2006-06-21
EP1268842A1 (de) 2003-01-02
WO2001066787A1 (en) 2001-09-13
ATE331038T1 (de) 2006-07-15
EP1268842A4 (de) 2003-09-17
DE60120942T2 (de) 2007-02-01

Similar Documents

Publication Publication Date Title
DE60126337D1 (de) Verfahren zum screenen für gpr40-liganden
DE50204719D1 (de) Verfahren zum bereitstellen von leistungsmerkmalen für alternativ-verbindungen von primär-verbindungen
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE323796T1 (de) Verfahren zum abtrennen von hemicellulosen aus hemicellulosehaltiger biomasse
ATE431853T1 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
ATE470722T1 (de) Strategien zur genexpressionsanalyse
CY1108471T1 (el) Μεθοδος για την παραγωγη εστερων σκοπινης
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
DE60215626D1 (de) Antagonist für die multimerisierung von hiv-1 vif-protein
ATE262178T1 (de) Identifizierung und charakterisierung von interagierenden molekülen
DE60131525D1 (de) Verfahren zum screening von inhibitoren für osteopontin
DE60120942D1 (de) Verbessertes verfahren für reverses n-hybrid-screening
DE69942544D1 (de) Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-2 gens und peptid davon
DE602004017018D1 (de) Verfahren zum zuweisen von objekten zu verarbeitungseinheiten
ATE445645T1 (de) Verfahren zur selektion von anti-angiogenese antikörperfragmenten
DE60238776D1 (de) Verfahren zum raffinieren von chromhaltigem schmelzflüssigem eisen
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE60202008D1 (de) Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten
DE69902924T2 (de) Neue methoden zum auffinden von liganden- und ziel-biomolekülen
DE50305695D1 (de) Verfahren zum nachweis und zur entfernung von endotoxin
DE602004030041D1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE394417T1 (de) Sonde zum nachweis von nukleinsäuren
DE60036794D1 (de) Proteomabbau
ATE353967T1 (de) Mutierte trichoderma reesei egiii cellulasen, dafür kodierende dna und verfahren zu deren herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee